Drugs / Amphotericin B Colloidal Dispersion
last change Apr 2023 re-read 2 minutes ago

Amphotericin B Colloidal Dispersion

Developed for
Cryptococcal meningitis
Investigated by
CSPC Ouyi Pharmaceutical Co., Ltd. · Peking Union Medical College Hospital

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT05471063 Aug 2022 → Feb 2023 Cryptococcal meningitis Peking Union Medical College Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Amphotericin B Colloidal Dispersion ClinicalTrials.gov intervention name — accepted as the source's own label NCT05471063